Google
×
Allogeneic stem cell transplantation from an HLA-identical sibling donor is a curative treatment option for a young patient with myelodysplastic syndrome.
Hematopoietic cell transplantation (HCT) is an effective treatment for myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML).
Missing: Haematopoietic Leukaemia
Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the chronic ...
dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the. European Group for Blood and ...
People also ask
Jul 5, 2007 · Hematopoietic cell transplantation (HCT) is an effective treatment for myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML).
Missing: Haematopoietic stem syndromes Leukaemia
The CMWP aims to contribute to improving outcomes for patients undergoing stem cell transplantation for chronic hematologic malignancies by the following means:.
Nov 24, 2022 · The sole curative therapy for myelodysplastic syndrome (MDS) is allogeneic hematopoietic cell transplantation (HCT).
Mar 30, 2017 · A recent study in 401 patients who received HSCT for MDS or MDS/acute myeloid leukemia (AML) showed that somatic mutations in ASXL1, RUNX1, or ...
The sole curative therapy for myelodysplastic syndrome (MDS) is allogeneic hematopoietic cell transplantation (HCT). Here this therapeutic modality is ...
Feb 1, 2018 · Relapse of the underlying disease is a major drawback of allogeneic hematopoietic stem cell transplantation (HSCT) for myelodysplastic syndrome ...